The Northern Cancer Center Requires The Acquisition Of Monoclonal Antibodies For Patient Treatments At The Northern Cancer Center To Resolve The Demand And Provide Continuity In The Care Of Chemotherapy Patients. The Objective Of This Tender Is To Carry Out A Supply Agreement With Those Suppliers That Are Awarded In Order To Ensure The Quantity, Quality And Timeliness Of The Drugs Necessary To Resolve The Healthcare Demand Of The Clinical Units Of The Northern Oncology Center.

DEL NORTE ONCOLOGY CENTER Chile has Released a tender for The Northern Cancer Center Requires The Acquisition Of Monoclonal Antibodies For Patient Treatments At The Northern Cancer Center To Resolve The Demand And Provide Continuity In The Care Of Chemotherapy Patients. The Objective Of This Tender Is To Carry Out A Supply Agreement With Those Suppliers That Are Awarded In Order To Ensure The Quantity, Quality And Timeliness Of The Drugs Necessary To Resolve The Healthcare Demand Of The Clinical Units Of The Northern Oncology Center. in Healthcare and Medicine. The tender was released on Apr 27, 2024.

Country - Chile

Summary - The Northern Cancer Center Requires The Acquisition Of Monoclonal Antibodies For Patient Treatments At The Northern Cancer Center To Resolve The Demand And Provide Continuity In The Care Of Chemotherapy Patients. The Objective Of This Tender Is To Carry Out A Supply Agreement With Those Suppliers That Are Awarded In Order To Ensure The Quantity, Quality And Timeliness Of The Drugs Necessary To Resolve The Healthcare Demand Of The Clinical Units Of The Northern Oncology Center.

Deadline - May 27, 2024

GT reference number - 81322286

Product classification - Medical equipments, pharmaceuticals and personal care products